{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:38:12Z","timestamp":1792600692673,"version":"4.5.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) has long been focused on the ovary and infertility aspects, rooted in the early observations by Stein and Leventhal (1935). The aggregated data, however, show that the syndrome has a wide comorbidity risk beyond fertility aspects involving several endocrine and metabolic derangements, yet without a true risk of ovarian cysts, benign or pathological, as expected with the old name. Moreover, with modern fertility care, women with the condition can reach cumulative childbirth rates comparable to those of unaffected women. The women may have spontaneous ovulations and pregnancies across the reproductive life course and, having high ovarian reserve, enter the menopause later. The endometrium and pregnancy complications have, however, been the blind spots in fertility care. Taking all this into account, in May 2026, a multi-step global consensus process culminating in a Lancet statement renamed the condition polyendocrine metabolic ovarian syndrome (PMOS), with transitional adoption already underway in current international guidance and consolidation into the next major international evidence-based guideline update scheduled for 2028. This opinion argues that the rename is not a cosmetic relabelling but a clinical mandate to widen fertility and pregnancy care, address fragmented care across primary, fertility, obstetric, and endocrine services, and acknowledge the endocrine, metabolic, psychological, and oncological burden. For Human\u2002Reproduction\u2019s readership, the 2028 guideline update is the concrete deadline around which language, registry coding, trial protocols, education, and clinical practice can align.<\/jats:p>","DOI":"10.1093\/humrep\/deag150","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:38:42Z","timestamp":1792597122000},"source":"Crossref","is-referenced-by-count":0,"title":["Releasing the syndrome from captivity: why renaming PCOS to PMOS widens reproductive care beyond the anovulatory frame"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-7300","authenticated-orcid":false,"given":"Terhi T","family":"Piltonen","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Research Unit of Clinical Medicine, Medical Research Center, Oulu University Hospital and University of Oulu , Oulu,","place":["Finland"]},{"name":"Reproductive Endocrinology and IVF Unit, Oulu University Hospital , Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-577X","authenticated-orcid":false,"given":"Helena J","family":"Teede","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation (MCHRI), Monash University , Melbourne, VIC,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Monash Health , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-1283","authenticated-orcid":false,"given":"Mahnaz","family":"Bahri Khomami","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation (MCHRI), Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"2026102111383631500_deag150-B1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/jc.2013-3996","article-title":"Polycystic ovary syndrome: what\u2019s in a name?","volume":"99","author":"Azziz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B2","first-page":"2","article-title":"How polycystic ovary syndrome came into its own","volume":"2","author":"Azziz","year":"2021","journal-title":"F S Sci"},{"key":"2026102111383631500_deag150-B3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/jmwh.13706","article-title":"Polycystic ovary syndrome as a key risk factor in pregnancy outcomes: a midwifery perspective from the international guideline","volume":"70","author":"Bahri Khomami","year":"2025","journal-title":"J Midwifery Womens Health"},{"key":"2026102111383631500_deag150-B4","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/s41467-024-49752-6","article-title":"Systematic review and meta-analysis of birth outcomes in women with polycystic ovary syndrome","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"2026102111383631500_deag150-B5","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/s41467-024-49752-6","article-title":"Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"2026102111383631500_deag150-B6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.fertnstert.2013.06.001","article-title":"Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors","volume":"100","author":"Bellver","year":"2013","journal-title":"Fertil Steril"},{"key":"2026102111383631500_deag150-B7","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1210\/jc.2017-01415","article-title":"Perspectives on polycystic ovary syndrome: is polycystic ovary syndrome research underfunded?","volume":"102","author":"Brakta","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","article-title":"Obesity and female infertility: potential mediators of obesity\u2019s impact","volume":"107","author":"Broughton","year":"2017","journal-title":"Fertil Steril"},{"key":"2026102111383631500_deag150-B9","doi-asserted-by":"crossref","DOI":"10.1530\/REP-25-0118","article-title":"Polycystic ovary syndrome: origins and implications: long-term health outcomes in polycystic ovary syndrome","volume":"170","author":"Dokras","year":"2025","journal-title":"Reproduction"},{"key":"2026102111383631500_deag150-B10","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/jc.2013-2040","article-title":"Renaming PCOS\u2014a two-state solution","volume":"11","author":"Dunaif","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary syndrome gain regular menstrual cycles when ageing","volume":"15","author":"Elting","year":"2000","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/s41591-025-03592-z","article-title":"Single-cell profiling of the human endometrium in polycystic ovary syndrome","volume":"31","author":"Eriksson","year":"2025","journal-title":"Nat Med"},{"key":"2026102111383631500_deag150-B13","doi-asserted-by":"crossref","first-page":"545.e1","DOI":"10.1016\/j.ajog.2024.11.010","article-title":"Fertility and age at childbirth in polycystic ovary syndrome: results from a longitudinal population-based cohort study","volume":"232","author":"Forslund","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"2026102111383631500_deag150-B1300","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41591-025-03984-1","volume":"31","author":"Gao","year":"2025","journal-title":"Nat Med"},{"key":"2026102111383631500_deag150-B14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"Glintborg","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026102111383631500_deag150-B15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B16","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/humrep\/deu020","article-title":"Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women\u2019s Health","volume":"29","author":"Joham","year":"2014","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/biolre\/ioz180","article-title":"Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1\u2020","volume":"102","author":"Khatun","year":"2020","journal-title":"Biol Reprod"},{"key":"2026102111383631500_deag150-B1900","first-page":"312","article-title":"Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study","volume":"5","author":"Kim","year":"2024","journal-title":"F S Rep"},{"key":"2026102111383631500_deag150-B19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0277-9536(01)00034-X","article-title":"The thief of womanhood\u2019: women\u2019s experience of polycystic ovarian syndrome","volume":"54","author":"Kitzinger","year":"2002","journal-title":"Soc Sci Med"},{"key":"2026102111383631500_deag150-B20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ejendo\/lvae057","article-title":"Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data","volume":"190","author":"Kujanp\u00e4\u00e4","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026102111383631500_deag150-B21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/aogs.70198","article-title":"Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: a population-based birth cohort study","volume":"105","author":"Lavi","year":"2026","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026102111383631500_deag150-B22","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/humrep\/dew264","article-title":"Common diseases as determinants of menopausal age","volume":"31","author":"Li","year":"2016","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41598-024-83568-0","article-title":"A risk prediction model for endometrial hyperplasia\/endometrial carcinoma in premenopausal women","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"2026102111383631500_deag150-B24","doi-asserted-by":"crossref","first-page":"eadu3699","DOI":"10.1126\/sciadv.adu3699","article-title":"Prenatally androgenized PCOS mice have ovary-independent uterine dysfunction and placental inflammation aggravated by high-fat diet","volume":"11","author":"Luyckx","year":"2025","journal-title":"Sci Adv"},{"key":"2026102111383631500_deag150-B2500","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/humrep\/deag127","volume":"41","author":"Luyckx","year":"2026","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/humrep\/deaf113","article-title":"PCOS endometrium-derived epithelial organoids as a novel model to study endometrial dysfunction","volume":"40","author":"Luyckx","year":"2025","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B26","doi-asserted-by":"crossref","first-page":"103587","DOI":"10.1016\/j.rbmo.2023.103587","article-title":"Endometrial preparation protocols prior to frozen embryo transfer\u2014convenience or safety?","volume":"48","author":"Magnusson","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"2026102111383631500_deag150-B27","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/aogs.14058","article-title":"The effect of different endometrial preparations on women with polycystic ovary syndrome undergoing initial frozen embryo transfer: a historical cohort analysis","volume":"100","author":"Man","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026102111383631500_deag150-B28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/humrep\/deaf212","article-title":"Recommendations from the WHO guideline for the prevention, diagnosis, and treatment of infertility\u2020","volume":"41","author":"Mburu","year":"2026","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B30","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1038\/s41598-023-40991-z","article-title":"Targeted gene expression profiling for accurate endometrial receptivity testing","volume":"13","author":"Meltsov","year":"2023","journal-title":"Sci Rep"},{"key":"2026102111383631500_deag150-B31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmad015","article-title":"PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis","volume":"29","author":"Mill\u00e1n-de-Meer","year":"2023","journal-title":"Hum Reprod Update"},{"key":"2026102111383631500_deag150-B32","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmaf030","article-title":"Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis","volume":"32","author":"Neven","year":"2026","journal-title":"Hum Reprod Update"},{"key":"2026102111383631500_deag150-B34","author":"NIH","year":"2012"},{"key":"2026102111383631500_deag150-B35","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1210\/clinem\/dgae527","article-title":"Economic burden of endometrial cancer associated with polycystic ovary syndrome","volume":"110","author":"Pace","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: a comprehensive review","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"key":"2026102111383631500_deag150-B37","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/humrep\/dez159","article-title":"Fecundity among women with polycystic ovary syndrome (PCOS)\u2014a population-based study","volume":"34","author":"Persson","year":"2019","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B38","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-M\u00fcllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bpobgyn.2016.03.008","article-title":"Polycystic ovary syndrome: endometrial markers","volume":"37","author":"Piltonen","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026102111383631500_deag150-B40","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/jc.2013-1923","article-title":"Mesenchymal stem\/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential","volume":"98","author":"Piltonen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B41","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/humrep\/dev055","article-title":"Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro","volume":"30","author":"Piltonen","year":"2015","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/ejendo\/lvad065","article-title":"AMH as part of the diagnostic PCOS workup in large epidemiological studies","volume":"188","author":"Piltonen","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026102111383631500_deag150-B43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamainternmed.2026.1370","article-title":"Ovarian cysts in polycystic ovary syndrome","volume":"186","author":"Piltonen","year":"2026","journal-title":"JAMA Intern Med"},{"key":"2026102111383631500_deag150-B44","doi-asserted-by":"crossref","first-page":"e0226074","DOI":"10.1371\/journal.pone.0226074","article-title":"Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe","volume":"14","author":"Piltonen","year":"2019","journal-title":"PLoS One"},{"key":"2026102111383631500_deag150-B45","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/jc.2011-0039","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS","volume":"96","author":"Puurunen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"1","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B47","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1038\/s41467-024-52898-y","article-title":"Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy","volume":"15","author":"S\u00e1nchez-Garrido","year":"2024","journal-title":"Nat Commun"},{"key":"2026102111383631500_deag150-B48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41467-026-68441-0","article-title":"Women with polycystic ovary syndrome exhibit impaired endometrial receptivity with excessive ER\u03b1 and histone lactylation","volume":"17","author":"Shan","year":"2026","journal-title":"Nat Commun"},{"key":"2026102111383631500_deag150-B49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6874-1-3","article-title":"Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports","volume":"1","author":"Sills","year":"2001","journal-title":"BMC Womens Health"},{"key":"2026102111383631500_deag150-B50","first-page":"343","article-title":"Multiple pregnancy following wedge resection in the Stein\u2013Leventhal syndrome","volume":"9","author":"Stein","year":"1964","journal-title":"Int J Fertil"},{"key":"2026102111383631500_deag150-B51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"2","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2026102111383631500_deag150-B52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2026102111383631500_deag150-B53","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1210\/jc.2013-2978","article-title":"Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome","volume":"99","author":"Teede","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102111383631500_deag150-B54","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41591-026-04456-w","article-title":"Naming in medicine: how disease nomenclature shapes diagnosis, research and patient lives","volume":"32","author":"Teede","year":"2026","journal-title":"Nat Med"},{"key":"2026102111383631500_deag150-B55","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"2026102111383631500_deag150-B56","doi-asserted-by":"crossref","first-page":"103287","DOI":"10.1016\/j.eclinm.2025.103287","article-title":"Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey","volume":"84","author":"Teede","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026102111383631500_deag150-B57","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026102111383631500_deag150-B58","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41574-026-01261-w","article-title":"Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes","volume":"22","author":"Teede","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"2026102111383631500_deag150-B59","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/humrep\/deac125","article-title":"Should any use of artificial cycle regimen for frozen-thawed embryo transfer in women capable of ovulation be abandoned: yes, but what\u2019s next for FET cycle practice and research?","volume":"37","author":"von Versen-H\u00f6ynck","year":"2022","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/humrep\/det437","article-title":"The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966","volume":"29","author":"West","year":"2014","journal-title":"Hum Reprod"},{"key":"2026102111383631500_deag150-B61","author":"WHO","year":"2026"},{"key":"2026102111383631500_deag150-B62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2019.04.014","article-title":"Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome","volume":"112","author":"Zhang","year":"2019","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/advance-article-pdf\/doi\/10.1093\/humrep\/deag150\/72256385\/deag150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/advance-article-pdf\/doi\/10.1093\/humrep\/deag150\/72256385\/deag150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:38:49Z","timestamp":1792597129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/advance-article\/doi\/10.1093\/humrep\/deag150\/8965103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":65,"URL":"https:\/\/doi.org\/10.1093\/humrep\/deag150","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"article-number":"deag150"}}